PE56194A1 - Composicion analgesica - Google Patents

Composicion analgesica

Info

Publication number
PE56194A1
PE56194A1 PE1993233164A PE23316493A PE56194A1 PE 56194 A1 PE56194 A1 PE 56194A1 PE 1993233164 A PE1993233164 A PE 1993233164A PE 23316493 A PE23316493 A PE 23316493A PE 56194 A1 PE56194 A1 PE 56194A1
Authority
PE
Peru
Prior art keywords
analgesic composition
composition
ibuprofeno
flurbiprofeno
antipoda
Prior art date
Application number
PE1993233164A
Other languages
English (en)
Spanish (es)
Inventor
Souza Richard Wilfred D
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE56194A1 publication Critical patent/PE56194A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1993233164A 1992-12-21 1993-12-17 Composicion analgesica PE56194A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99437192A 1992-12-21 1992-12-21

Publications (1)

Publication Number Publication Date
PE56194A1 true PE56194A1 (es) 1995-01-26

Family

ID=25540587

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1993233164A PE56194A1 (es) 1992-12-21 1993-12-17 Composicion analgesica

Country Status (9)

Country Link
EP (1) EP0674517A1 (zh)
JP (1) JPH08504818A (zh)
CN (1) CN1094615A (zh)
AU (1) AU672279B2 (zh)
BR (1) BR9307697A (zh)
CA (1) CA2149317A1 (zh)
MX (1) MX9400038A (zh)
PE (1) PE56194A1 (zh)
WO (1) WO1994014449A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09502202A (ja) * 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー プロピオン酸非ステロイド系抗炎症剤のアミノ酸塩とカフェインを含有した組成物
EP0841947A1 (en) * 1995-07-28 1998-05-20 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
KR101517064B1 (ko) * 2006-04-28 2015-04-30 그뤼넨탈 게엠베하 3-(3-디메틸아미노-1-에틸-2-메틸-프로필)-페놀 및 ｎｓａｉｄ를 포함하는 약제학적 병용제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
AU6758990A (en) * 1989-11-06 1991-05-31 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
CA2092566A1 (en) * 1990-09-28 1992-03-29 Thomas N. Gates Ibuprofen-antihistamine combinations

Also Published As

Publication number Publication date
BR9307697A (pt) 1999-05-25
EP0674517A1 (en) 1995-10-04
JPH08504818A (ja) 1996-05-28
CN1094615A (zh) 1994-11-09
CA2149317A1 (en) 1994-07-07
MX9400038A (es) 1994-07-29
WO1994014449A1 (en) 1994-07-07
AU672279B2 (en) 1996-09-26
AU5899394A (en) 1994-07-19

Similar Documents

Publication Publication Date Title
ATE41739T1 (de) Feste orale dosierungsformulierungen von kardiovaskularen heilmitteln mit konstanter freisetzungsgeschwindigkeit.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
NO179250C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv (+)--(2,3-dimetoksyfenyl)-1-[2-(4-fluorfenyl)etylÅ-4-piperidinmetanol
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
NZ295303A (en) Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
IT1206341B (it) Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
DK0535327T3 (da) Farmaceutisk præparat indeholdende felbinac
AR064895A2 (es) Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina
ES2122283T3 (es) Inhibicion del crecimiento capilar.
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
ES2171933T3 (es) Derivados de androsteno.
BR0013935A (pt) IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
ATE15596T1 (de) Pharmazeutische mittel.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
MX9304564A (es) Combinaciones de relajante muscular-ibuprofen.
ES2161292T3 (es) Composicion de higiene oral.
PE56194A1 (es) Composicion analgesica
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
AR001765A1 (es) Una formulación de liberación prolongada un procedimiento para su preparación una forma cristalina de cisaprida-(l)-tartrato y un medicamento util para el tratamiento de trastornos gastrointestinales
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ES2083490T3 (es) 3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed